The Leadership Team at Sorrento Therapeutics is responsible for setting the strategic direction and operational oversight of the company, focusing on advancing antibody-based therapies for cancer and autoimmune diseases. This team, comprising top executives in regulatory affairs, commercial operations, and biotechnology, ensures compliance with industry standards, drives market strategies, and fosters innovation to bring new treatment options to patients. Their collaborative efforts are crucial in navigating the complexities of the biopharmaceutical landscape while aligning with Sorrento’s mission.
View all